E. L. Vartanyan, R.S. Polyakov, L. Dyachuk, D.V. Fetzer, Y. Arutyunova, N.A. Karanadze, M.A. Trukhanova, N. A. Mironov, S.T. Matskeplishvili
{"title":"用于指导慢性冠状动脉综合征和多支血管冠状动脉疾病患者血管内治疗策略的分数血流储备评估","authors":"E. L. Vartanyan, R.S. Polyakov, L. Dyachuk, D.V. Fetzer, Y. Arutyunova, N.A. Karanadze, M.A. Trukhanova, N. A. Mironov, S.T. Matskeplishvili","doi":"10.32756/0869-5490-2023-4-41-44","DOIUrl":null,"url":null,"abstract":"To evaluate the impact of fractional flow reserve (FFR) assessment on the choice of the myocardial revascularization strategy in patients with ischemic heart disease and multivessel coronary artery disease and to compare the long-term outcomes of complete functional or anatomical revascularization.","PeriodicalId":10353,"journal":{"name":"Clinical pharmacology and therapy","volume":"57 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Fractional flow reserve assessment for guiding the strategy of endovascular treatment of patients with chronic coronary syndrome and multivessel coronary artery disease\",\"authors\":\"E. L. Vartanyan, R.S. Polyakov, L. Dyachuk, D.V. Fetzer, Y. Arutyunova, N.A. Karanadze, M.A. Trukhanova, N. A. Mironov, S.T. Matskeplishvili\",\"doi\":\"10.32756/0869-5490-2023-4-41-44\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"To evaluate the impact of fractional flow reserve (FFR) assessment on the choice of the myocardial revascularization strategy in patients with ischemic heart disease and multivessel coronary artery disease and to compare the long-term outcomes of complete functional or anatomical revascularization.\",\"PeriodicalId\":10353,\"journal\":{\"name\":\"Clinical pharmacology and therapy\",\"volume\":\"57 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-11-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical pharmacology and therapy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.32756/0869-5490-2023-4-41-44\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical pharmacology and therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.32756/0869-5490-2023-4-41-44","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Fractional flow reserve assessment for guiding the strategy of endovascular treatment of patients with chronic coronary syndrome and multivessel coronary artery disease
To evaluate the impact of fractional flow reserve (FFR) assessment on the choice of the myocardial revascularization strategy in patients with ischemic heart disease and multivessel coronary artery disease and to compare the long-term outcomes of complete functional or anatomical revascularization.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
